Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Ladenburg Thalmann Downgrades NextCure to Neutral

Ladenburg Thalmann Downgrades NextCure to Neutral

Ladenburg Thalmann analyst Aydin Huseynov downgrades NextCure (NASDAQ:NXTC) from Buy to Neutral.

November 4, 2022

1 minute read

Ladenburg Thalmann analyst Aydin Huseynov downgrades NextCure (NASDAQ:NXTC) from Buy to Neutral.

Dow Surges Over 100 Points; Foot Locker Earnings Top Views

November 18, 11:12 AM

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 100 points on Friday.

June 12, 10:44 AM

Signet Jewelers Limited (NYSE:SIG) will release earnings results for its first quarter, before the opening bell on Thursday.…

September 29, 11:29 AM

Planet Labs PBC (NYSE: PL) announced that NASA has

May 3, 2:30 PM

Cadence Design Sys (NASDAQ:CDNS) has outperformed the market over the past 15 years by 14.18% on an annualized…